IL-1α, IL-1β, and IFN-γ mark β cells for Fas-dependent destruction by diabetogenic CD4+ T lymphocytes

Journal of Clinical Investigation

Volumn 105, Issue 4, 2000, Pages 459-468

  Amrani, Abdelaziz ^a   Verdaguer, Joan ^a   Thiessen, Shari ^a   Sonny, Bou ^a   Santamaria, Pere ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; CHROMIUM; CYTOKINE; FAS LIGAND; FASL PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; INTERLEUKIN 1; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CYTOLYSIS; DIABETES MELLITUS; DIABETOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GENETICS; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MOUSE MUTANT; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREATITIS; SPLEEN;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CHROMIUM RADIOISOTOPES; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; INTERLEUKIN-1; ISLETS OF LANGERHANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED MRL LPR; MICE, INBRED NOD; MICE, MUTANT STRAINS; PANCREATITIS; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033621893     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8185     Document Type: Article

References (48)

1. Delovitch, T., and Singh, B. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune disregulation gets the NOD. Immunity. 7:727-738.
2. Lee, M.-S., and Sarvetnick, N. 1992. Transgenes in autoimmunity. Curr. Opin. Immunol. 4:723-727.
3. Gianani, R., and Sarvetnick, N. 1996. Viruses, cytokines, antigens and autoimmunitv. Proc. Natl. Acad. Sci. USA. 93:2257-2259.
4. Rabinovitch, A. 1999. Cytokines in the pathogenesis of type 1 diabetes. Can. J. Diabetes Care. 23:40-51.
5. + T-cells from diabetic versus prediabetic NOD.NON-thy-1a donors. Diabetes. 42:44-55.
6. Katz, J., Benoist, C., and Mathis, D. 1993. Major histocompatibility complex class 1 molecules are required for the generation of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:3358-3360.
7. Wicker, L., et al. 1994. β2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 43:500-504.
8. null mice are diabetes and insulitis resistant. Diabetes. 43:505-508.
9. null nonobese diabetic mice. J. Immunol. 157:3688-3693.
10. Serreze, D., et al. 1997. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 157:3978-3986.
11. Peterson, J., and Haskins, K. 1996. Transfer of diabetes in the NOD-scid mouse by CD4 T cell clones. Differential requirement for CD8 T cells. Diabetes. 45:328-336.
12. + cells in pancreatic islets of NOD mice. Diabetes, 40:648-651.
13. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R., and Hengartner, H. 1995. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol. Rev. 146:95-115.
14. Kagi, D., et al. 1997 Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186:989-997.
15. Itoh, N., et al. 1997. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:613-618.
16. Chervonsky, A., et al. 1997. The role of Fas in autoimmune diabetes. Cell. 89:17-24.
17. Hahn, S., Geri, R., and Erb, P. 1995. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:57-79.
18. + CTL that utilizes a perforin rather than a Fas ligand dependent cytotoxic mechanism. J. Immunol. 156:153-159.
19. Schmidt, D., Verdaguer, J., Averill, N., and Santamaria, P. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059-1075.
20. Verdaguer, J., et al. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663-1676.
21. + T lymphocytes in transgenic nonobese diabetic mice. J. Clin. Invest. 103:1201-1209.
22. Nicoletti, I., Migliorati, G., Pagliacci, M., Grignani, F., and Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
23. + T cells expressing identical endogenous TCRα chains. J. Immunol. 157:4726-4735.
24. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 96:9311-9316.
25. Yamada, K., Takane-Gyotoku, N., Ichikawa, F., Inada, C., and Nokada, K. 1996. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia. 39:1306-1312.
26. Stassi, G., et al. 1997. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186:1193-1199.
27. Heitmeier, M., Scarim, A., and Corbett, J. 1997. IFN-γ increases the sensitivity of islets of Langerhans for inducible nitric oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272:13697-13705.
28. Thomas, H.E., Darwiche, R., Corbett, J.A., and Kay, T.W. 1999. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J. Immunol. 163:1562-1569.
29. Bretz, J.D., Arscott, P.L., Myc, A., and Baker, J.R., Jr. 1999. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J. Biol. Chem. 274:25433-25438.
30. Clark, W., et al. 1995. Molecular pathways of CTL-mediated cytotoxicity. Immunol. Rev. 146:33-44.
31. Allison, J., and Strasser, A. 1998. Mechanisms of beta cell death in diabetes: a minor role for CD95. Proc. Natl. Acad. Sci. USA. 95:13818-13822.
32. + T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA. 88:527-531.
33. Lo, D., et al. 1993. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur. J. Immunol. 23:1693-1698.
34. Sarvetnick, N., et al. 1990. Loss of pancreatic islet tolerance induced by beta cell-expression of interferon-gamma. Nature. 346:844-847.
35. Thomas, H., Parker, J., Schreiber, R., and Kay, T. 1998. INF-γ action on panreatic beta cells causes class I MHC upregulation but not diabetes. J. Clin. Invest. 102:1249-1257.
36. Stewart, T., et al. 1993. Induction of type I diabetes by interferon-alpha in transgenic mice. Science. 260:1942-1946.
37. Higuchi, Y., et al. 1992. Expression of a tumor necrosis factor-α transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719-1726.
38. Picarella, D., Kratz, A., Li, C., Ruddle, N., and Flavell, R. 1992. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA. 89:10036-10041.
39. Sabelko, K., Kelly, K., Nahm, M., Cross, A., and Russell, J. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:3096-3099.
40. Waldner, H., Sobel, R., Howard, E., and Kuchroo, V. 1997. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100-3103.
41. Thilenius, A., Sabelko-Downes, K., and Russell, J. 1999. The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis. J. Immunol. 162:643-650.
42. + T-cells in T-cell receptor transgenic NOD mice. Diabetes. 48:34-42.
43. Jun, H., Yoon, C., Zbytnuik, L., Rooijen, N.V., and Yoon, J. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189:347-358.
44. + thymocytes by protective MHC class II molecules. J. Immunol. 162: 4627-4636.
45. + T helper 1 effectors. J. Immunol. 157:2961-2969.
46. + T cells by a self-derived peptide. Nature. 378:295-298.
47. Signore, A., et al. 1997. CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. Diabetologia. 40:1476-1479.
48. Pakala, S., Chivetta, M., Kelly, C., and Katz, J. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an inslet cell response to tumor necrosis factor α. J. Exp. Med. 189:1053-1062.